Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus - PubMed (original) (raw)
- PMID: 3301484
- PMCID: PMC7087521
- DOI: 10.1007/BF00299027
Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus
A K Foulis et al. Diabetologia. 1987 May.
Abstract
Twenty-three patients with recent onset Type 1 (insulin-dependent) diabetes in whom residual insulin secreting B cells were present and 12 patients with disease of more prolonged duration (maximum 9 years), 8 of whom had residual B cells, were studied. Aberrant expression of Class II major histocompatibility complex molecules was demonstrated immunohistochemically on insulin secreting B cells in 21 out of 23 patients with recent onset disease and 6 of the patients with more prolonged disease. No such expression was seen on glucagon secreting A cells or somatostatin secreting D cells. Islets where there was marked hyperexpression of Class I major histocompatibility complex molecules on islet endocrine cells were seen in all cases in which residual B cells were present. Ninety-two per cent of insulin containing islets but only 1% of insulin deficient islets exhibited this phenomenon (p less than 0.001, Chi-squared test). There was evidence to suggest that both these abnormalities of major histocompatibility complex expression preceded insulitis within a given islet. They also appeared to be unique to Type 1 diabetes, being absent in pancreases of patients with Type 2 (non-insulin-dependent) diabetes, chronic pancreatitis, cystic fibrosis, graft-versus-host disease and Coxsackie B viral pancreatitis. The development of autoimmunity to B cells in Type 1 diabetes may be a "multistep" process in which abnormalities of major histocompatibility complex expression on islet endocrine cells are crucial events.
Similar articles
- C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
Foulis AK. Foulis AK. J Pathol. 1987 Jul;152(3):141-8. doi: 10.1002/path.1711520302. J Pathol. 1987. PMID: 3309229 Review. - Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus.
Foulis AK, Farquharson MA, Meager A. Foulis AK, et al. Lancet. 1987 Dec 19;2(8573):1423-7. doi: 10.1016/s0140-6736(87)91128-7. Lancet. 1987. PMID: 2891993 - Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, et al. Itoh N, et al. J Clin Invest. 1993 Nov;92(5):2313-22. doi: 10.1172/JCI116835. J Clin Invest. 1993. PMID: 8227346 Free PMC article. - Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes.
Richardson SJ, Rodriguez-Calvo T, Gerling IC, Mathews CE, Kaddis JS, Russell MA, Zeissler M, Leete P, Krogvold L, Dahl-Jørgensen K, von Herrath M, Pugliese A, Atkinson MA, Morgan NG. Richardson SJ, et al. Diabetologia. 2016 Nov;59(11):2448-2458. doi: 10.1007/s00125-016-4067-4. Epub 2016 Aug 9. Diabetologia. 2016. PMID: 27506584 Free PMC article. - The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus.
Foulis AK. Foulis AK. APMIS. 1996 Mar;104(3):161-7. doi: 10.1111/j.1699-0463.1996.tb00702.x. APMIS. 1996. PMID: 8611188 Review.
Cited by
- HLA A*24:02-restricted T cell receptors cross-recognize bacterial and preproinsulin peptides in type 1 diabetes.
Dolton G, Bulek A, Wall A, Thomas H, Hopkins JR, Rius C, Galloway SA, Whalley T, Tan LR, Morin T, Omidvar N, Fuller A, Topley K, Hasan MS, Jain S, D'Souza N, Hodges-Hoyland T; TIRID Consortium; Spiller OB, Kronenberg-Versteeg D, Szomolay B, van den Berg HA, Jones LC, Peakman M, Cole DK, Rizkallah PJ, Sewell AK. Dolton G, et al. J Clin Invest. 2024 Sep 17;134(18):e164535. doi: 10.1172/JCI164535. J Clin Invest. 2024. PMID: 39286976 Free PMC article. - Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes.
Roy S, Pokharel P, Piganelli JD. Roy S, et al. Mol Metab. 2024 Oct;88:101998. doi: 10.1016/j.molmet.2024.101998. Epub 2024 Jul 26. Mol Metab. 2024. PMID: 39069156 Free PMC article. Review. - The immunology of type 1 diabetes.
Herold KC, Delong T, Perdigoto AL, Biru N, Brusko TM, Walker LSK. Herold KC, et al. Nat Rev Immunol. 2024 Jun;24(6):435-451. doi: 10.1038/s41577-023-00985-4. Epub 2024 Feb 2. Nat Rev Immunol. 2024. PMID: 38308004 Free PMC article. Review. - Autoimmune diseases: targets, biology, and drug discovery.
Li SJ, Wu YL, Chen JH, Shen SY, Duan J, Xu HE. Li SJ, et al. Acta Pharmacol Sin. 2024 Apr;45(4):674-685. doi: 10.1038/s41401-023-01207-2. Epub 2023 Dec 14. Acta Pharmacol Sin. 2024. PMID: 38097717 Review. - The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes.
Russell MA, Richardson SJ, Morgan NG. Russell MA, et al. Front Endocrinol (Lausanne). 2023 Oct 6;14:1270325. doi: 10.3389/fendo.2023.1270325. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37867531 Free PMC article. Review.
References
- Bottazzo GF. Beta-Cell damage in diabetic insulitis: are we approaching a solution? Diabetologia. 1984;26:241–249. - PubMed
- Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965;14:619–633. - PubMed
- Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in Type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients unter 20 years of age in the United Kingdom. Diabetologia. 1986;29:267–274. - PubMed
- Wolf E, Spencer KM, Cudworth AG. The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia. 1983;24:224–230. - PubMed
- Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. The Lancet. 1983;2:1115–1118. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical